Viral DNA polymerase — Drug Target

All drugs that target Viral DNA polymerase — marketed and clinical-stage. Includes 4 drug classes acting on this target.

Drug classes

Nucleoside analogue · Nucleotide analog antiviral · nucleoside analog · Nucleoside analog antiviral

Marketed (1)

• VALACYCLOVIR · Nucleoside analogue · Metabolic
  Valacyclovir is an antiviral drug that inhibits viral DNA polymerase to treat herpes simplex and varicella-zoster viruses.

Phase 3 pipeline (4)

• Cidofovir intravenous · Johns Hopkins Bloomberg School of Public Health · Nucleotide analog antiviral · Infectious Disease / Virology
  Cidofovir is a nucleotide analog that inhibits viral DNA polymerase, preventing viral DNA replication in infected cells.
• acyclovir in ME-609 vehicle · Medivir · nucleoside analog · Infectious Diseases
  Acyclovir is an antiviral medication that inhibits viral DNA synthesis by inhibiting viral DNA polymerase.
• NOV03 · Bausch & Lomb Incorporated · nucleoside analog · Infectious Diseases
  NOV03 is an investigational antiviral medication.
• Acyclovir 5 percent (Perrigo) · Padagis LLC · Nucleoside analog antiviral · Infectious Disease / Virology
  Acyclovir is a nucleoside analog that inhibits viral DNA polymerase, preventing herpes simplex virus and varicella-zoster virus from replicating.